TY - JOUR AU - Koelink, Pim J. AU - Lamers, Cornelis BHW AU - Hommes, Daan W. AU - Verspaget, Hein W. PY - 2009 DA - 2009/03/23 TI - Circulating cell death products predict clinical outcome of colorectal cancer patients JO - BMC Cancer SP - 88 VL - 9 IS - 1 AB - Tumor cell death generates products that can be measured in the circulation of cancer patients. CK18-Asp396 (M30 antigen) is a caspase-degraded product of cytokeratin 18 (CK18), produced by apoptotic epithelial cells, and is elevated in breast and lung cancer patients. SN - 1471-2407 UR - https://doi.org/10.1186/1471-2407-9-88 DO - 10.1186/1471-2407-9-88 ID - Koelink2009 ER -